Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-25 @ 7:54 PM
NCT ID:
NCT04988035
Group ID:
EG000
Title:
Remdesivir + Danicopan
Description:
200 mg intravenous (IV) loading dose of Remdesivir on Day 1, followed by a 100 mg once-daily IV maintenance dose up to a 10-day total course while hospitalized, and 400 mg oral (PO) for participants \< 70 years or 300 mg PO for participants \>=70 years(or via nasogastric \[NG\] or gastrostomy \[G\] tube) loading dose danicopan, followed by 250 mg 4 times daily (QID) for participants \<70years (200mg for participants\>=70 years 4 times QID) for the duration of the hospitalization up to a 14-day total course. End of danicopan treatment tapered as 250 mg (or 200mg for \>=70 years) 3 times daily (TID) for 2 days, followed by 250 mg (or 200mg for \>=70 years) twice daily (BID) for 2 days, until complete cessation (total treatment duration up to 18 days or 4 days after discharge).
Deaths Number Affected:
19
Deaths Number At Risk:
None
Serious Number Affected:
31
Serious Number At Risk:
96
Other Number Affected:
8
Other Number At Risk:
96
Study:
NCT04988035
Results Section:
NCT04988035
Adverse Events Module:
NCT04988035